Yunnan PanLong YunHai Pharmaceuticals, Ltd. Report issue

For profit Phase 2
Founded: Kunming China (1995)
Status: No NME R&D (1995)

Organization Overview

First Clinical Trial
2016
NCT04069715
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Yunnan PanLongYunHai Pharmaceuticals, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

ginseng (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperlipidemias (Phase 2)

Hyperlipoproteinemias (Phase 2)

Hypertension (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1